Hussman Strategic Advisors, Inc. Tg Therapeutics, Inc. Transaction History
Hussman Strategic Advisors, Inc.
- $428 Million
- Q3 2025
A detailed history of Hussman Strategic Advisors, Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 126,000 shares of TGTX stock, worth $4.19 Million. This represents 1.06% of its overall portfolio holdings.
Number of Shares
126,000
Previous 126,000
-0.0%
Holding current value
$4.19 Million
Previous $4.53 Million
0.4%
% of portfolio
1.06%
Previous 1.11%
Shares
5 transactions
Others Institutions Holding TGTX
# of Institutions
404Shares Held
91.6MCall Options Held
2.28MPut Options Held
1.68M-
Vanguard Group Inc Valley Forge, PA15.5MShares$516 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$379 Million0.0% of portfolio
-
State Street Corp Boston, MA7.62MShares$253 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$116 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY3.05MShares$102 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.83B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...